"the final time point measurement showed no difference between...

 "the final time point measurement showed no difference between the two treatment groups</em>".

This quote is from the second last paragraph of "Daviste's analysis" does it for me .....he is wrong plane and simple, and davisite having misinterpreted the data so badly points to "other" agendas. When I first read his post I almost made the same error myself, the  CD4+ levels at the end of the treatment should not be elevated . The point being there were effected by Bit225.

"and cleared by week 12"

I dont think Michelle has been very clear in the poster or the letter but she does say that there has been a very different immune response in CD4+ between 225 and placebo.

I expect a deal in the new year

I am a hold unless the price drops below 10 but I have been around for 15 years with BIT and I wont let the deal pass me by. I did take some profit because there is risk which I sought to minimize as BIT had become too big in my portfolio.

Eat em alive Michelle!